- Home
- NRXS vs GECC Comparison
NRXS vs GECC Comparison
Compare NRXS & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NRXS | GECC |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance: Consumer Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.9M | 84.6M |
| IPO Year | 2023 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NRXS | GECC |
|---|---|---|
| Price | $5.97 | $6.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $13.00 | $10.75 |
| AVG Volume (30 Days) | ★ 89.0K | 49.8K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 22.06% |
| EPS Growth | ★ 22.13 | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | ★ $3,569,282.00 | N/A |
| Revenue This Year | $172.91 | $0.92 |
| Revenue Next Year | $115.71 | N/A |
| P/E Ratio | ★ N/A | $14.61 |
| Revenue Growth | ★ 32.89 | N/A |
| 52 Week Low | $2.21 | $4.63 |
| 52 Week High | $9.33 | $11.45 |
Technical Indicators
Market Signals| Indicator | NRXS | GECC |
|---|---|---|
| Relative Strength Index (RSI) | 39.42 | 62.23 |
| Support Level | $5.59 | $5.38 |
| Resistance Level | $7.54 | $6.34 |
| Average True Range (ATR) | 0.35 | 0.18 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 43.67 | 80.56 |
Price Performance
Historical ComparisonAbout NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generates both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses. The Company operates as a single reportable segment with an investment objective to generate both current income and capital appreciation through debt and equity investments and manages the business on a consolidated basis.